Cargando…

Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis

Doxorubicin (DOX) is a powerful chemotherapeutic agent used in many types of malignancies. However, its use results in testicular damage. DOX-induced testicular damage results in low level of serum testosterone which may affect cognitive function. The current study investigated the protective effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Alafifi, Shorouk A., Wahdan, Sara A., Elhemiely, Alzahraa A., Elsherbiny, Doaa A., Azab, Samar S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567954/
https://www.ncbi.nlm.nih.gov/pubmed/37162541
http://dx.doi.org/10.1007/s00210-023-02504-7
_version_ 1785119251542048768
author Alafifi, Shorouk A.
Wahdan, Sara A.
Elhemiely, Alzahraa A.
Elsherbiny, Doaa A.
Azab, Samar S.
author_facet Alafifi, Shorouk A.
Wahdan, Sara A.
Elhemiely, Alzahraa A.
Elsherbiny, Doaa A.
Azab, Samar S.
author_sort Alafifi, Shorouk A.
collection PubMed
description Doxorubicin (DOX) is a powerful chemotherapeutic agent used in many types of malignancies. However, its use results in testicular damage. DOX-induced testicular damage results in low level of serum testosterone which may affect cognitive function. The current study investigated the protective effect of liraglutide (50, 100 μg/kg/day) in testicular toxicity and the consequent cognitive impairment induced by DOX. DOX treatment reduced sperm count (62%) and sperm motility (53%) and increased sperm abnormalities (786%), as compared to control group. DOX also reduced serum testosterone level (85%) and the gene expression of testicular 3β-HSD (68%) and 17β-HSD (82%). Moreover, it increased testicular oxidative stress (MDA and GSH) by 103% and 59%, respectively, apoptotic (caspase-3 and P53) by 996% and 480%, respectively. In addition, DOX resulted in increasing autophagic markers including PAKT, mTOR, and LC3 by 48%, 56%, and 640%, respectively. Additionally, rats’ behavior in Y-maze (60%) and passive avoidance task (85%) was disrupted. The histopathological results of testis and brain supported the biochemical findings. Treatment with liraglutide (100 μg/kg/day) significantly abrogated DOX-induced testicular damage by restoring testicular architecture, increasing sperm count (136%) and sperm motility (106%), and decreasing sperm abnormalities (84%) as compared to DOX group. Furthermore, liraglutide increased serum testosterone (500%) and steroidogenesis enzymes 3β-HSD (105%) and 17β-HSD (181%) along with suppressing oxidative stress (MDA and GSH) by 23% and 85%, respectively; apoptotic (caspase-3 and P53) by 59% and55%, respectively; and autophagic markers including PAKT, mTOR, and LC3 by 48%, 97%, and 60%, respectively. Moreover, it enhanced the memory functions in passive avoidance and Y-maze tests (132%). In conclusion, liraglutide is a putative agent for protection against DOX-induced testicular toxicity and cognitive impairment through its antioxidant, antiapoptotic, and antiautophagic effects. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00210-023-02504-7.
format Online
Article
Text
id pubmed-10567954
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-105679542023-10-13 Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis Alafifi, Shorouk A. Wahdan, Sara A. Elhemiely, Alzahraa A. Elsherbiny, Doaa A. Azab, Samar S. Naunyn Schmiedebergs Arch Pharmacol Research Doxorubicin (DOX) is a powerful chemotherapeutic agent used in many types of malignancies. However, its use results in testicular damage. DOX-induced testicular damage results in low level of serum testosterone which may affect cognitive function. The current study investigated the protective effect of liraglutide (50, 100 μg/kg/day) in testicular toxicity and the consequent cognitive impairment induced by DOX. DOX treatment reduced sperm count (62%) and sperm motility (53%) and increased sperm abnormalities (786%), as compared to control group. DOX also reduced serum testosterone level (85%) and the gene expression of testicular 3β-HSD (68%) and 17β-HSD (82%). Moreover, it increased testicular oxidative stress (MDA and GSH) by 103% and 59%, respectively, apoptotic (caspase-3 and P53) by 996% and 480%, respectively. In addition, DOX resulted in increasing autophagic markers including PAKT, mTOR, and LC3 by 48%, 56%, and 640%, respectively. Additionally, rats’ behavior in Y-maze (60%) and passive avoidance task (85%) was disrupted. The histopathological results of testis and brain supported the biochemical findings. Treatment with liraglutide (100 μg/kg/day) significantly abrogated DOX-induced testicular damage by restoring testicular architecture, increasing sperm count (136%) and sperm motility (106%), and decreasing sperm abnormalities (84%) as compared to DOX group. Furthermore, liraglutide increased serum testosterone (500%) and steroidogenesis enzymes 3β-HSD (105%) and 17β-HSD (181%) along with suppressing oxidative stress (MDA and GSH) by 23% and 85%, respectively; apoptotic (caspase-3 and P53) by 59% and55%, respectively; and autophagic markers including PAKT, mTOR, and LC3 by 48%, 97%, and 60%, respectively. Moreover, it enhanced the memory functions in passive avoidance and Y-maze tests (132%). In conclusion, liraglutide is a putative agent for protection against DOX-induced testicular toxicity and cognitive impairment through its antioxidant, antiapoptotic, and antiautophagic effects. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00210-023-02504-7. Springer Berlin Heidelberg 2023-05-10 2023 /pmc/articles/PMC10567954/ /pubmed/37162541 http://dx.doi.org/10.1007/s00210-023-02504-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Alafifi, Shorouk A.
Wahdan, Sara A.
Elhemiely, Alzahraa A.
Elsherbiny, Doaa A.
Azab, Samar S.
Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis
title Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis
title_full Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis
title_fullStr Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis
title_full_unstemmed Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis
title_short Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis
title_sort modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567954/
https://www.ncbi.nlm.nih.gov/pubmed/37162541
http://dx.doi.org/10.1007/s00210-023-02504-7
work_keys_str_mv AT alafifishorouka modulatoryeffectofliraglutideondoxorubicininducedtesticulartoxicityandbehavioralabnormalitiesinratsroleoftesticularbrainaxis
AT wahdansaraa modulatoryeffectofliraglutideondoxorubicininducedtesticulartoxicityandbehavioralabnormalitiesinratsroleoftesticularbrainaxis
AT elhemielyalzahraaa modulatoryeffectofliraglutideondoxorubicininducedtesticulartoxicityandbehavioralabnormalitiesinratsroleoftesticularbrainaxis
AT elsherbinydoaaa modulatoryeffectofliraglutideondoxorubicininducedtesticulartoxicityandbehavioralabnormalitiesinratsroleoftesticularbrainaxis
AT azabsamars modulatoryeffectofliraglutideondoxorubicininducedtesticulartoxicityandbehavioralabnormalitiesinratsroleoftesticularbrainaxis